Latest GeneTherapy News and Updates : GeneTherapy updates, GeneTherapy News , GeneTherapy around the world

Nishadil

Washington | 23°C (heavy intensity rain)

Himachal Pradesh Eyes Non‑Practicing Allowance for Specialist Doctors

Top story

Himachal Pradesh Eyes Non‑Practicing Allowance for Specialist Doctors

In focus

Latest feed

A Week of Groundbreaking Insights: UNC School of Medicine Faculty Make Waves in Health and Research

The Symphony of Sound: A Miracle Unfolds in Boston

Echoes of Hope: Gene Therapy's Promise for Restoring Hearing

Krystal Biotech Soars: RBC Capital Markets Sees Billions in Gene Therapy Potential

Latest headlines

Krystal Biotech Shines Bright: RBC Capital Markets Sees Major Upside

Krystal Biotech Shines Bright: RBC Capital Markets Sees Major Upside

A New Chapter for Gene Editing: Scribe Therapeutics Takes Nasdaq by Storm with Upsized IPO

A New Chapter for Gene Editing: Scribe Therapeutics Takes Nasdaq by Storm with Upsized IPO

CRISPR Therapeutics: On the Cusp of a New Era in Medicine

CRISPR Therapeutics: On the Cusp of a New Era in Medicine

Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line

Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line

Gene Therapy Reverses Age‑Related Hearing Loss in Mice, Study Shows

Gene Therapy Reverses Age‑Related Hearing Loss in Mice, Study Shows

A Breakthrough Cure: Gene Therapy Stops Sickle Cell in Its Tracks

A Breakthrough Cure: Gene Therapy Stops Sickle Cell in Its Tracks

A Breakthrough in Sickle‑Cell Care: One Man’s Journey to a Functional Cure

A Breakthrough in Sickle‑Cell Care: One Man’s Journey to a Functional Cure

A Breakthrough for Gene Editing: Unlocking CRISPR's Full Potential

A Breakthrough for Gene Editing: Unlocking CRISPR's Full Potential

A Tiny Trove of Inner‑Ear Cells Could Change the Way We Treat Hearing Loss

A Tiny Trove of Inner‑Ear Cells Could Change the Way We Treat Hearing Loss

Regeneron Pharmaceuticals (REGN) Shareholder Call: Numbers, Pipeline, and What’s Next

Regeneron Pharmaceuticals (REGN) Shareholder Call: Numbers, Pipeline, and What’s Next

Chamath Palihapitiya Joins Forces with Eli Lilly to Target LDL Cholesterol with Gene‑Editing Therapy

Chamath Palihapitiya Joins Forces with Eli Lilly to Target LDL Cholesterol with Gene‑Editing Therapy

The End of Heart Disease? Scientists Unveil a 'One-and-Done' Prevention Dream

The End of Heart Disease? Scientists Unveil a 'One-and-Done' Prevention Dream

A Breakthrough in Mitochondrial Gene Editing: Scientists Unveil Precision Tool

A Breakthrough in Mitochondrial Gene Editing: Scientists Unveil Precision Tool

How Gene‑Therapy Is Turning the Tide Against Tumors

How Gene‑Therapy Is Turning the Tide Against Tumors

Regenxbio's Gene Therapy Journey Hits a Couple of Bumps in the Road

Regenxbio's Gene Therapy Journey Hits a Couple of Bumps in the Road

REGENXBIO's Rollercoaster Ride: A Tale of Two Gene Therapies

REGENXBIO's Rollercoaster Ride: A Tale of Two Gene Therapies

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

A Glimpse of Tomorrow: How Gene Therapy is Restoring Sight and Inspiring Hope

A Glimpse of Tomorrow: How Gene Therapy is Restoring Sight and Inspiring Hope

UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children

UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children

The Gene Therapy Race: Is America Losing Ground to China's Rapid Advance?

The Gene Therapy Race: Is America Losing Ground to China's Rapid Advance?

A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

uniQure Soars: Mizuho Upgrade Rekindles Hope for Huntington's Gene Therapy

uniQure Soars: Mizuho Upgrade Rekindles Hope for Huntington's Gene Therapy

A Critical Eye on Progress: FDA Official Questions uniQure's Huntington's Trial Comparisons

A Critical Eye on Progress: FDA Official Questions uniQure's Huntington's Trial Comparisons

The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine

The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine

A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial

A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial

Unlocking the Brain's Secrets: A New Dawn in the Fight Against Alzheimer's

Unlocking the Brain's Secrets: A New Dawn in the Fight Against Alzheimer's

The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning

The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning

The End of an Era: Doug Ingram Prepares to Retire from Sarepta, Elizabeth Barrett Named Successor

The End of an Era: Doug Ingram Prepares to Retire from Sarepta, Elizabeth Barrett Named Successor

Sana Biotechnology: A Deep Dive into a Speculative Biotech Bet

Sana Biotechnology: A Deep Dive into a Speculative Biotech Bet

Why Did Regenxbio (RGNX) Shares Take Such a Steep Dive After Hours? Unpacking the Gene Therapy News

Why Did Regenxbio (RGNX) Shares Take Such a Steep Dive After Hours? Unpacking the Gene Therapy News

A Mother's Strength: Jesy Nelson Shares Daughter Alara's SMA Journey

A Mother's Strength: Jesy Nelson Shares Daughter Alara's SMA Journey

$The Quiet Revolution: Taming Cellular Chaos with a Biological Noise Controller$

The Quiet Revolution: Taming Cellular Chaos with a Biological Noise Controller

BillionToOne: A Biotech Innovator Poised for a Breakthrough by 2026?

BillionToOne: A Biotech Innovator Poised for a Breakthrough by 2026?

A Mother's Unwavering Fight for Her Daughter's Future

A Mother's Unwavering Fight for Her Daughter's Future

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

A Glimmer of Hope: CRISPR's Promise for Children with Pura Syndrome

A Glimmer of Hope: CRISPR's Promise for Children with Pura Syndrome

A New Dawn for 'Bubble Babies': Revolutionary Gene Therapy Offers Full Immune Reboot

A New Dawn for 'Bubble Babies': Revolutionary Gene Therapy Offers Full Immune Reboot

Load more